Notice: This company has been marked as potentially delisted and may not be actively trading. Diffusion Pharmaceuticals (DFFN) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Comparing diffusion, osmosis and active transportApril 18, 2024 | bbc.co.ukDiffusion Pharmaceuticals Inc.February 10, 2024 | thestreet.comVertex co-founder Josh Boger joins Boston biotech working on dementia drugFebruary 8, 2024 | bizjournals.comStable Video Diffusion is now available through Stability AI APIDecember 22, 2023 | venturebeat.comDiffusion Pharmaceuticals Inc.: Diffusion Pharmaceuticals Stockholders Approve Merger with EIP PharmaAugust 16, 2023 | finanznachrichten.deDiffusion Pharmaceuticals Inc.: Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma / Announces 1-for-1.5 Reverse Stock SplitAugust 16, 2023 | finanznachrichten.deDiffusion Pharmaceuticals Stockholders Approve Merger with EIP PharmaAugust 15, 2023 | finance.yahoo.comDiffusion Pharmaceuticals Inc. (DFFN) stock forecast and price targetJuly 24, 2023 | finance.yahoo.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FOCS, RADI, BGRY, DFFNMay 23, 2023 | benzinga.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Diffusion Pharmaceuticals Inc. MergerMarch 31, 2023 | marketwatch.comDFFN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Diffusion Pharmaceuticals Inc. Is Fair to ShareholdersMarch 30, 2023 | technews.tmcnet.comDiffusion to merge with EIP Pharma in all-stock dealMarch 30, 2023 | msn.comEIP Pharma and Diffusion Pharmaceuticals Announce Merger Agreement to Create Leading CNS-focused Company Treating Neurodegenerative DiseasesMarch 30, 2023 | finance.yahoo.comDiffusion's Shareholder LifeSci Supports Company's Strategic Review Process And Director NomineesDecember 16, 2022 | markets.businessinsider.comDiffusion Pharmaceuticals Announces Agreement with LifeSci Special OpportunitiesDecember 16, 2022 | finance.yahoo.comDiffusion Pharmaceuticals Sends Letter to Stockholders Highlighting Strength of Board Leadership and Positive Progress in Strategic Review, Cautioning Stockholders Regarding LifeSci’s History of Stockholder Value Destruction and Self-DealingDecember 5, 2022 | finance.yahoo.comDFFN: Strategic Review Underway; Planning to Initiate Phase 2 GBM Trial in 1Q23…December 1, 2022 | finance.yahoo.comDiffusion Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business UpdateNovember 15, 2022 | finance.yahoo.comDiffusion Pharmaceuticals Sees Significant Progress in its Strategic Review ProcessNovember 14, 2022 | finance.yahoo.comDiffusion PharmaceuticalsOctober 15, 2022 | forbes.comDiffusion Pharmaceuticals Inc. (DFFN)September 29, 2022 | finance.yahoo.comDiffusion raised to Buy at H.C. Wainwright after Q2 update on lead assetAugust 17, 2022 | seekingalpha.comDFFN: Phase 2 GBM Trial to Initiate 2H22…August 17, 2022 | finance.yahoo.comDiffusion Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business UpdateAugust 11, 2022 | finance.yahoo.comDiffusion Pharmaceuticals to Initiate Phase 2 Trial in Patients with Glioblastoma Multiforme Incorporating Innovative Imaging Methodology to Evaluate Tumor OxygenationJuly 26, 2022 | finance.yahoo.comDiffusion Pharmaceuticals Announces Positive Effects in Altitude TrialJune 23, 2022 | finance.yahoo.comDFFN: Data from Altitude Trial Expected in June 2022…May 20, 2022 | finance.yahoo.comDiffusion Pharmaceuticals Announces Appointment of Raven Jaeger, M.S., as Chief Regulatory OfficerMay 18, 2022 | finance.yahoo.comDiffusion Pharmaceuticals to Present at H.C. Wainwright Global Investment ConferenceMay 17, 2022 | finance.yahoo.comDiffusion Pharmaceuticals GAAP EPS of -$2.22May 14, 2022 | seekingalpha.comDiffusion Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business UpdateMay 13, 2022 | finance.yahoo.comDiffusion Pharmaceuticals Regains Compliance With Nasdaq Listing RequirementsMay 4, 2022 | finance.yahoo.com5 Stocks Halted In Tuesday's SessionApril 19, 2022 | markets.businessinsider.comDiffusion Pharma Falls 18% After Announcing Reverse Stock SplitApril 19, 2022 | nasdaq.comTrading was temporarily halted for "DFFN" at 09:04 AM with a stated reason of "LULD pause."April 19, 2022 | marketbeat.comDiffusion Pharmaceuticals Inc.: Diffusion Pharmaceuticals Announces 1-for-50 Reverse Stock Split as Part of Nasdaq Compliance PlanApril 19, 2022 | finanznachrichten.deWhy Diffusion Pharmaceuticals Shares Are FallingApril 18, 2022 | uk.investing.comDiffusion Pharma crashes after announcing reverse stock splitApril 18, 2022 | seekingalpha.comDiffusion Pharmaceuticals' 50-For-1 Stock Split Will Go Into Effect TomorrowApril 18, 2022 | finance.yahoo.comDiffusion Pharmaceuticals Announces 1-for-50 Reverse Stock Split as Part of Nasdaq Compliance PlanApril 18, 2022 | finance.yahoo.comDiffusion Pharmaceuticals Completes Dosing in Altitude TrialApril 11, 2022 | finance.yahoo.comDiffusion Pharmaceuticals Announces New Date for Previously Announced Special Meeting of StockholdersApril 8, 2022 | finance.yahoo.comDiffusion Pharmaceuticals Announces New Date for Previously Announced Special Meeting of StockholdersApril 8, 2022 | finance.yahoo.comDFFN: Additional Tissue Oxygenation Trial Results Expected Mid-2022…March 23, 2022 | finance.yahoo.comDiffusion Pharmaceuticals Reports 2021 Financial Results and Provides Business UpdateMarch 21, 2022 | finance.yahoo.comWe're Keeping An Eye On Diffusion Pharmaceuticals' (NASDAQ:DFFN) Cash Burn RateMarch 9, 2022 | finance.yahoo.comDiffusion Pharmaceuticals Expands its Scientific Advisory Board with the Addition of Leading Radiation and Medical Oncology ExpertsFebruary 24, 2022 | finance.yahoo.comDiffusion Pharmaceuticals to Present at H.C. Wainwright BioConnect, Participate in Biotech Showcase and Bio Partnering at JPM during “J.P. Morgan Week 2022”December 20, 2021 | finance.yahoo.comDiffusion Pharmaceuticals Doses First Patients in ILD-DLCO TrialDecember 16, 2021 | finance.yahoo.comDiffusion Pharmaceuticals Announces Issuance of U.S. Patent 11,185,523December 1, 2021 | finance.yahoo.com Get Diffusion Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for DFFN and its competitors with MarketBeat's FREE daily newsletter. Email Address Man Who Called Nvidia Says: “Your Retirement Is Inside This Building.” (Ad)In 2016, Jeff Brown called Nvidia at a split-adjusted 66 cents. The company just became the world's third $3 trillion company... And the stock is up massively since Jeff's recommendation. Now, Jeff has found five under-the-radar stocks which could power your retirement. DFFN Media Mentions By Week DFFN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DFFN News Sentiment▼0.000.63▲Average Medical News Sentiment DFFN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DFFN Articles This Week▼00▲DFFN Articles Average Week Get Diffusion Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for DFFN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LTRN News Today CPIX News Today GDTC News Today RNXT News Today COCP News Today VRCA News Today KALA News Today SLGL News Today FBRX News Today MRKR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DFFN) was last updated on 1/1/2025 by MarketBeat.com Staff From Our Partnersliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Diffusion Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Diffusion Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
